ADVANCE Chest CT
Comprehensive chest CT analysis for lung cancer, ILD, and COPD detection and quantification
Software · EmbeddedCompany source
Company profile
About Contextflow
contextflow is a medical imaging AI company specializing in comprehensive chest CT analysis for radiologists, PACS vendors, and pharmaceutical companies. As a spinoff of the Medical University of Vienna, the company develops AI-powered clinical decision support tools that detect, quantify, and manage lung cancer, lung diseases, and incidental pulmonary embolism in clinical routine. Their flagship product, ADVANCE Chest CT, provides radiologists with nodule detection and tracking, quantitative lung tissue analysis for 19 image patterns, and qualitative analysis with reference cases and differential diagnosis information—all integrated directly into native PACS viewers. The platform supports lung cancer screening programs, including Germany's nationwide initiative developed in partnership with Mint Medical. contextflow's approach emphasizes transparency over black-box AI, designed to support radiologist workflow while leaving final clinical decisions to physicians. The company's solutions enable quantitative disease profiling, longitudinal tracking through their TIMELINE feature, and evidence-based reporting that has demonstrated a 31% reduction in average report reading time in clinical studies. With a foundation in peer-reviewed research and regulatory clearances, contextflow serves health systems, radiology departments, and pharmaceutical partners across Europe and globally, helping clinicians improve diagnostic accuracy, reduce unnecessary procedures, and enhance patient outcomes in pulmonary care.
Company description Contextflow official website
Primary marketMedical Imaging & Radiology
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at Contextflow?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- Atelectasis
- Bronchiectasis
- Consolidation
- COPD
- Emphysema
- Ground-glass opacity
- Honeycombing
- Incidental pulmonary embolism (iPE)
- Interstitial lung disease (ILD)
- Lung cancer
- Pleural effusion
- Pneumothorax
- Pulmonary nodules
- Reticular pattern
Who it serves
- Academic medical centers
- Health Systems
- PACS vendors
- Pharmaceutical companies
- Radiologists
Deployment & integration
Embedded deployment with recorded integration context.
Recorded integration context: Native radiology viewers, PACS systems.
Geographic context
MarketsAustria · Europe · Germany · Netherlands · United Kingdom · USA (under development)
Company sourceOfficial website
Company milestones
Platform expansion
Acquired by 4DMedical in 2024/2025. Developed lung cancer screening solution with Mint Medical for Germany's nationwide screening program. RevealAI-Lung became first radiology AI to receive reimbursement in Europe (Germany).
Partnerships
Recorded partners
- 4DMedical (acquired contextflow)
- Avicenna (CINA-iPE provider)
- Erasmus MC
- Freiburg University Medical Center
- Leiden University Medical Center
- Medical University of Innsbruck
- Medical University of Mainz
- Medical University of Vienna
- Mint Medical (lung cancer screening collaboration)
- NHS SW London Imaging Network
- Providence Little Company of Mary Medical Centers
- RevealDx (RevealAI-Lung provider)
- Vienna General Hospital
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
CINA-iPE
Automatic detection and prioritization of incidental pulmonary embolism
Software · EmbeddedCompany source
Lung Cancer Screening Solution
Comprehensive workflow solution for Germany's nationwide lung cancer screening program
Software · EmbeddedCompany source
RevealAI-Lung
Malignancy scoring for lung nodules to reduce false positives and enable earlier cancer detection
Software · EmbeddedCompany source
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
Ultra-low-dose vs. standard-of-care-dose CT of the chest in patients with post-COVID-19 conditions-a prospective intra-patient multi-reader study.European radiology · Nov 1, 2024
Towards the adoption of quantitative computed tomography in the management of interstitial lung disease.European respiratory review : an official journal of the European Respiratory Society · Jan 31, 2024
Impact of a content-based image retrieval system on the interpretation of chest CTs of patients with diffuse parenchymal lung disease.European radiology · Jan 1, 2023
Deep learning detection and quantification of pneumothorax in heterogeneous routine chest computed tomography.European radiology experimental · Apr 17, 2020
Clinical validation
Clinical-trial records
Evaluation of Contextflow DETECT Lung CT Nodule Detection Software in Chest CT ScansNCT05481762 · Sponsor · COMPLETED
Regulatory
Regulatory records
No linked records are currently available.
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
31% reduction in average report reading time
Clinical study with Medical University of Vienna
18% reduction in false positives
RevealAI-Lung malignancy scoring
45% increase in early diagnosis possible
RevealAI-Lung for lung cancer detection
Medical University of Vienna
Clinical study evaluating impact of contextflow ADVANCE Chest CT on radiology workflow efficiency
31% reduction in average report reading time
Erasmus MC
Clinical decision support tools for chest CT analysis in clinical practice
Freiburg University Medical Center
Transparent AI solution supporting radiologist workflow for chest CT analysis
Leiden University Medical Center
Follow-up scan analysis using TIMELINE view for returning patients
Medical University of Innsbruck
Daily clinical use for interstitial lung disease quantification and disease progression tracking
Quantified disease progression information now included in radiology reports for improved clinical decision making
Medical University of Mainz
Pattern recognition in routine scans for staging and disease evaluation, serving as double checker
NHS SW London Imaging Network
Safe and ethical AI implementation for medical imaging
Providence Little Company of Mary Medical Centers
Next generation AI to support radiologists with comprehensive finding recognition
Vienna General Hospital
Evaluation of deep learning technology for lung diseases to improve hospital experience
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Updates from Contextflow
Recent articles published on Contextflow's official website.
contextflow collaborates with VUNO and Mesalvo to advance cardiac arrest prediction solution
Read on Contextflowcontextflow & Curagita partner to improve lung cancer and lung disease diagnostics in Germany
Read on Contextflowcontextflow & Mint Medical collaborate on lung cancer screening webinar series
Read on ContextflowUZ Leuven and contextflow Collaborate on a Pilot to Advance Chest Imaging Analysis
Read on ContextflowMalignancy Scoring in Limburg-Weilburg: A decisive step into the future
Read on Contextflow07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Medical Imaging & Radiology
Companies that apply AI to analyze medical images for diagnostic purposes, workflow optimization, or clinical decision support. Covers general radiology (X-rays, CT scans, MRIs, ultrasounds) across multiple organ systems, as well as specialized imaging in ophthalmology and dermatology.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.